Anxiety sensitivity (AS) is a well-established, malleable risk factor for anxiety and other forms of psychopathology. Structural evaluation models of AS suggest it can be decomposed into physical, social, and cognitive concerns, and emerging work indicates that these components may be differentially related to various adverse outcomes. In particular, AS cognitive concerns have been consistently linked with suicide. Prior work has also shown that brief interventions can effectively reduce overall AS, but these treatments tend to focus on its physical subcomponent. The aim of the current investigation was to design and evaluate the efficacy of an AS treatment more specifically focused on its cognitive component.